Why is Shree Ganesh Bio falling/rising?

As of 18-Nov, Shree Ganesh Biotech India Ltd is experiencing a decline in its stock price, currently at Rs. 0.69, which reflects a decrease of Rs. 0.01 or 1.43%. The stock has hit a new 52-week low of Rs. 0.67 today and has underperformed its sector by 0.38%. Over the past week, the stock has decreased by 4.17%, and its year-to-date performance shows a significant drop of 33.65%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. However, there has been a rise in investor participation, with delivery volume increasing by 29.38% compared to the 5-day average, suggesting some interest despite the overall negative performance. In the broader market context, the Sensex has shown a positive return of 0.96% over the past week, contrasting sharply with Shree Ganesh Biotech's decline. This disparity highlights the stock's underperformance relative to the benchmark index. Over the last month, while the Sensex has gained 0.86%, Shree Ganesh Biotech has fallen by 6.76%, further emphasizing its struggle in the current market environment. The lack of positive factors in the provided data suggests that there are no significant catalysts to support a recovery in the stock price at this time.